These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 24791951

  • 1. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
    Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, Paripovic L, Klingspor L, Nordøy I, Hamal P, Arikan Akdagli S, Ossi C, Grancini A, Cavanna C, Lo Cascio G, Scarparo C, Candoni A, Caira M, Drogari Apiranthitou M, ECMM Working Group.
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
    [Abstract] [Full Text] [Related]

  • 2. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
    Tupaki-Sreepurna A, Thanneru V, Natarajan S, Sharma S, Gopi A, Sundaram M, Kindo AJ.
    Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
    [Abstract] [Full Text] [Related]

  • 3. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, van Diepeningen AD.
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [Abstract] [Full Text] [Related]

  • 4. Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis.
    Rosa PDD, Ramirez-Castrillon M, Borges R, Aquino V, Meneghello Fuentefria A, Zubaran Goldani L.
    J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
    [Abstract] [Full Text] [Related]

  • 5. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M, Shobana CS, Singh YR, Manikandan P, Selvam KP, Kredics L, Narendran V, Vágvölgyi C, Galgóczy L.
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [Abstract] [Full Text] [Related]

  • 6. Genotyping of Fusarium Isolates from Onychomycoses in Colombia: Detection of Two New Species Within the Fusarium solani Species Complex and In Vitro Antifungal Susceptibility Testing.
    Guevara-Suarez M, Cano-Lira JF, de García MC, Sopo L, De Bedout C, Cano LE, García AM, Motta A, Amézquita A, Cárdenas M, Espinel-Ingroff A, Guarro J, Restrepo S, Celis A.
    Mycopathologia; 2016 Apr; 181(3-4):165-74. PubMed ID: 26943726
    [Abstract] [Full Text] [Related]

  • 7. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
    Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, Melhem TM, Pelaez T, Pfaller MA, Szeszs MW, Takahaschi JP, Tortorano AM, Wiederhold NP, Turnidge J.
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
    [Abstract] [Full Text] [Related]

  • 8. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
    Taj-Aldeen SJ, Salah H, Al-Hatmi AM, Hamed M, Theelen B, van Diepeningen AD, Boekhout T, Lass-Flörl C.
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
    [Abstract] [Full Text] [Related]

  • 9. Emergence of fusarioses in a university hospital in Turkey during a 20-year period.
    Dalyan Cilo B, Al-Hatmi AM, Seyedmousavi S, Rijs AJ, Verweij PE, Ener B, de Hoog GS, van Diepeningen AD.
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1683-91. PubMed ID: 25994844
    [Abstract] [Full Text] [Related]

  • 10. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF.
    J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
    [Abstract] [Full Text] [Related]

  • 11. Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India.
    Tupaki-Sreepurna A, Al-Hatmi AM, Kindo AJ, Sundaram M, de Hoog GS.
    Mycoses; 2017 Apr; 60(4):230-233. PubMed ID: 27766684
    [Abstract] [Full Text] [Related]

  • 12. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
    Song Y, Liu X, Yang Z, Meng X, Xue R, Yu J, Al-Hatmi AMS, de Hoog GS, Li R.
    Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
    [Abstract] [Full Text] [Related]

  • 13. Fusarium musae as cause of superficial and deep-seated human infections.
    Esposto MC, Prigitano A, Tortorano AM.
    J Mycol Med; 2016 Dec; 26(4):403-405. PubMed ID: 27091579
    [Abstract] [Full Text] [Related]

  • 14. Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.
    Boral H, van Diepeningen A, Erdem E, Yağmur M, de Hoog GS, Ilkit M, Meis JF, Al-Hatmi AMS.
    Mycopathologia; 2018 Oct; 183(5):835-840. PubMed ID: 29931660
    [Abstract] [Full Text] [Related]

  • 15. Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature.
    Al-Hatmi AM, Bonifaz A, Tirado-Sánchez A, Meis JF, de Hoog GS, Ahmed SA.
    Mycoses; 2017 Mar; 60(3):204-212. PubMed ID: 27928841
    [Abstract] [Full Text] [Related]

  • 16. Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis.
    Sun S, Lui Q, Han L, Ma Q, He S, Li X, Zhang H, Zhang J, Liu X, Wang L.
    Sci Rep; 2018 Mar 20; 8(1):4859. PubMed ID: 29559666
    [Abstract] [Full Text] [Related]

  • 17. Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.
    Pereira GH, de Angelis DA, Brasil RA, dos Anjos Martins M, de Matos Castro e Silva D, Szeszs MW, de Souza Carvalho Melhem M.
    Mycopathologia; 2013 Feb 20; 175(1-2):107-14. PubMed ID: 23076561
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients.
    Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE.
    Antimicrob Agents Chemother; 2019 Aug 20; 63(8):. PubMed ID: 31182529
    [Abstract] [Full Text] [Related]

  • 19. Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.
    Milanez EPR, de Souza PFSM, Monteiro RC, Pereira LMG, Peixoto PHS, de Oliveira DFG, Colares PPR, Teixeira RF, Andrade MFCE, Silva JV, Rodrigues AM, de Souza Collares Maia DCB, Cordeiro RA.
    Mycoses; 2024 May 20; 67(5):e13728. PubMed ID: 38695201
    [Abstract] [Full Text] [Related]

  • 20. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
    Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL.
    J Antimicrob Chemother; 2008 Apr 20; 61(4):805-9. PubMed ID: 18263569
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.